APO Research
Talk to an analyst

APO RESEARCH · REPORT

Renal Drugs

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Renal Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

19 December 2025185 pages

Choose your research edition.

Industry ResearchRenal Drugs Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Renal Drugs Industry Growth and Trends Forecast to 203289 pages · $3,450 USDMarket StructureGlobal Renal Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032185 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Renal Drugs Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Renal Drugs Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Renal Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Renal Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Renal Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Renal Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Renal Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Renal Drugs include Mylan, Roche Holding, Fresenius, Endo International, Dava Pharmaceuticals, Cardinal Health, Bausch Health Companies and Apotex, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Renal Drugs market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Renal Drugs and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Renal Drugs revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Renal Drugs market size, projected growth trends, production technologies, key applications, and end-use industries.

Renal Drugs Segment by Company

Mylan

Roche Holding

Fresenius

Endo International

Dava Pharmaceuticals

Cardinal Health

Bausch Health Companies

Apotex

Renal Drugs Segment by Type

Oral

Injections

Renal Drugs Segment by Application

Hospital Pharmacy

Drug Stores

Online Pharmacy

Retail Pharmacies

Others

Renal Drugs Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Renal Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Renal Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Renal Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Renal Drugs in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Renal Drugs industry.

Chapter 3: Detailed analysis of Renal Drugs companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Renal Drugsrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Renal Drugs Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Oral Table 3. Key Players of Injections Table 4. Global Renal Drugs Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Hospital Pharmacy Table 6. Key Players of Drug Stores Table 7. Key Players of Online Pharmacy Table 8. Key Players of Retail Pharmacies Table 9. Key Players of Others Table 10. Global Renal Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 11. Global Renal Drugs Market Size by Region (2021-2026) & (US$ Million) Table 12. Global Renal Drugs Market Share by Region (2021-2026) Table 13. Global Renal Drugs Market Size by Region (2027-2032) & (US$ Million) Table 14. Global Renal Drugs Market Share by Region (2027-2032) Table 15. Renal Drugs Industry Trends Table 16. Renal Drugs Industry Drivers Table 17. Renal Drugs Industry Opportunities and Challenges Table 18. Renal Drugs Industry Restraints Table 19. Global Renal Drugs Revenue by Company (US$ Million) & (2021-2026) Table 20. Global Renal Drugs Revenue Market Share by Company (2021-2026) Table 21. Global Renal Drugs Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 22. Global Renal Drugs Key Company Head Office and Area Served Table 23. Global Renal Drugs Company, Product Type & Application Table 24. Global Renal Drugs Company Establishment Date Table 25. Global Company Market Concentration Ratio (CR5 and HHI) Table 26. Global Renal Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 27. Global Renal Drugs Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Renal Drugs Market Size by Type (2021-2026) & (US$ Million) Table 29. Global Renal Drugs Market Size by Type (2027-2032) & (US$ Million) Table 30. Global Renal Drugs Revenue Market Share by Type (2021-2026) Table 31. Global Renal Drugs Revenue Market Share by Type (2027-2032) Table 32. Global Renal Drugs Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Renal Drugs Market Size by Application (2021-2026) & (US$ Million) Table 34. Global Renal Drugs Market Size by Application (2027-2032) & (US$ Million) Table 35. Global Renal Drugs Revenue Market Share by Application (2021-2026) Table 36. Global Renal Drugs Revenue Market Share by Application (2027-2032) Table 37. Mylan Company Information Table 38. Mylan Business Overview Table 39. Mylan Renal Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. Mylan Renal Drugs Product Portfolio Table 41. Mylan Recent Development Table 42. Roche Holding Company Information Table 43. Roche Holding Business Overview Table 44. Roche Holding Renal Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. Roche Holding Renal Drugs Product Portfolio Table 46. Roche Holding Recent Development Table 47. Fresenius Company Information Table 48. Fresenius Business Overview Table 49. Fresenius Renal Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. Fresenius Renal Drugs Product Portfolio Table 51. Fresenius Recent Development Table 52. Endo International Company Information Table 53. Endo International Business Overview Table 54. Endo International Renal Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. Endo International Renal Drugs Product Portfolio Table 56. Endo International Recent Development Table 57. Dava Pharmaceuticals Company Information Table 58. Dava Pharmaceuticals Business Overview Table 59. Dava Pharmaceuticals Renal Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. Dava Pharmaceuticals Renal Drugs Product Portfolio Table 61. Dava Pharmaceuticals Recent Development Table 62. Cardinal Health Company Information Table 63. Cardinal Health Business Overview Table 64. Cardinal Health Renal Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. Cardinal Health Renal Drugs Product Portfolio Table 66. Cardinal Health Recent Development Table 67. Bausch Health Companies Company Information Table 68. Bausch Health Companies Business Overview Table 69. Bausch Health Companies Renal Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. Bausch Health Companies Renal Drugs Product Portfolio Table 71. Bausch Health Companies Recent Development Table 72. Apotex Company Information Table 73. Apotex Business Overview Table 74. Apotex Renal Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 75. Apotex Renal Drugs Product Portfolio Table 76. Apotex Recent Development Table 77. North America Renal Drugs Market Size by Type (2021-2026) & (US$ Million) Table 78. North America Renal Drugs Market Size by Type (2027-2032) & (US$ Million) Table 79. North America Renal Drugs Market Size by Application (2021-2026) & (US$ Million) Table 80. North America Renal Drugs Market Size by Application (2027-2032) & (US$ Million) Table 81. North America Renal Drugs Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 82. North America Renal Drugs Market Size by Country (2021-2026) Table 83. North America Renal Drugs Market Size by Country (2027-2032) Table 84. Europe Renal Drugs Market Size by Type (2021-2026) & (US$ Million) Table 85. Europe Renal Drugs Market Size by Type (2027-2032) & (US$ Million) Table 86. Europe Renal Drugs Market Size by Application (2021-2026) & (US$ Million) Table 87. Europe Renal Drugs Market Size by Application (2027-2032) & (US$ Million) Table 88. Europe Renal Drugs Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 89. Europe Renal Drugs Market Size by Country (2021-2026) Table 90. Europe Renal Drugs Market Size by Country (2027-2032) Table 91. China Renal Drugs Market Size by Type (2021-2026) & (US$ Million) Table 92. China Renal Drugs Market Size by Type (2027-2032) & (US$ Million) Table 93. China Renal Drugs Market Size by Application (2021-2026) & (US$ Million) Table 94. China Renal Drugs Market Size by Application (2027-2032) & (US$ Million) Table 95. Asia Renal Drugs Market Size by Type (2021-2026) & (US$ Million) Table 96. Asia Renal Drugs Market Size by Type (2027-2032) & (US$ Million) Table 97. Asia Renal Drugs Market Size by Application (2021-2026) & (US$ Million) Table 98. Asia Renal Drugs Market Size by Application (2027-2032) & (US$ Million) Table 99. Asia Renal Drugs Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 100. Asia Renal Drugs Market Size by Country (2021-2026) Table 101. Asia Renal Drugs Market Size by Country (2027-2032) Table 102. South America, Middle East & Africa Renal Drugs Market Size by Type (2021-2026) & (US$ Million) Table 103. South America, Middle East & Africa Renal Drugs Market Size by Type (2027-2032) & (US$ Million) Table 104. South America, Middle East & Africa Renal Drugs Market Size by Application (2021-2026) & (US$ Million) Table 105. South America, Middle East & Africa Renal Drugs Market Size by Application (2027-2032) & (US$ Million) Table 106. South America, Middle East & Africa Renal Drugs Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 107. South America, Middle East & Africa Renal Drugs Market Size by Country (2021-2026) Table 108. South America, Middle East & Africa Renal Drugs Market Size by Country (2027-2032) Table 109. Research Programs/Design for This Report Table 110. Authors List of This Report Table 111. Secondary Sources Table 112. Primary Sources List of Figures Figure 1. Renal Drugs Product Image Figure 2. Global Renal Drugs Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Renal Drugs Market Share by Type: 2025 VS 2032 Figure 4. Oral Image Figure 5. Injections Image Figure 6. Global Renal Drugs Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 7. Global Renal Drugs Market Share by Application: 2025 VS 2032 Figure 8. Hospital Pharmacy Image Figure 9. Drug Stores Image Figure 10. Online Pharmacy Image Figure 11. Retail Pharmacies Image Figure 12. Others Image Figure 13. Global Renal Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Renal Drugs Market Size (2021-2032) & (US$ Million) Figure 15. Global Renal Drugs Market Share by Region: 2025 VS 2032 Figure 16. Years Considered Figure 17. Global Renal Drugs Market Share by Players in 2025 Figure 18. Global Top 5 and 10 Renal Drugs Players Market Share by Revenue in 2025 Figure 19. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Renal Drugs Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Renal Drugs Revenue Market Share by Type (2021-2032) Figure 22. Global Renal Drugs Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Renal Drugs Revenue Market Share by Application (2021-2032) Figure 24. North America Renal Drugs Market Size (2021-2032) & (US$ Million) Figure 25. North America Renal Drugs Market Share by Type (2021-2032) Figure 26. North America Renal Drugs Market Share by Application (2021-2032) Figure 27. North America Renal Drugs Market Share by Country (2021-2032) Figure 28. United States Renal Drugs Market Size (2021-2032) & (US$ Million) Figure 29. Canada Renal Drugs Market Size (2021-2032) & (US$ Million) Figure 30. Mexico Renal Drugs Market Size (2021-2032) & (US$ Million) Figure 31. Europe Renal Drugs Market Size (2021-2032) & (US$ Million) Figure 32. Europe Renal Drugs Market Share by Type (2021-2032) Figure 33. Europe Renal Drugs Market Share by Application (2021-2032) Figure 34. Europe Renal Drugs Market Share by Country (2021-2032) Figure 35. Germany Renal Drugs Market Size (2021-2032) & (US$ Million) Figure 36. France Renal Drugs Market Size (2021-2032) & (US$ Million) Figure 37. U.K. Renal Drugs Market Size (2021-2032) & (US$ Million) Figure 38. Italy Renal Drugs Market Size (2021-2032) & (US$ Million) Figure 39. Russia Renal Drugs Market Size (2021-2032) & (US$ Million) Figure 40. Nordic Countries Renal Drugs Market Size (2021-2032) & (US$ Million) Figure 41. China Renal Drugs Market Size (2021-2032) & (US$ Million) Figure 42. China Renal Drugs Market Share by Type (2021-2032) Figure 43. China Renal Drugs Market Share by Application (2021-2032) Figure 44. Asia Renal Drugs Market Size (2021-2032) & (US$ Million) Figure 45. Asia Renal Drugs Market Share by Type (2021-2032) Figure 46. Asia Renal Drugs Market Share by Application (2021-2032) Figure 47. Asia Renal Drugs Market Share by Country (2021-2032) Figure 48. Japan Renal Drugs Market Size (2021-2032) & (US$ Million) Figure 49. South Korea Renal Drugs Market Size (2021-2032) & (US$ Million) Figure 50. Taiwan Renal Drugs Market Size (2021-2032) & (US$ Million) Figure 51. Southeast Asia Renal Drugs Market Size (2021-2032) & (US$ Million) Figure 52. India Renal Drugs Market Size (2021-2032) & (US$ Million) Figure 53. Australia Renal Drugs Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa Renal Drugs Market Size (2021-2032) & (US$ Million) Figure 55. South America, Middle East & Africa Renal Drugs Market Share by Type (2021-2032) Figure 56. South America, Middle East & Africa Renal Drugs Market Share by Application (2021-2032) Figure 57. South America, Middle East & Africa Renal Drugs Market Share by Country (2021-2032) Figure 58. Brazil Renal Drugs Market Size (2021-2032) & (US$ Million) Figure 59. South Africa Renal Drugs Market Size (2021-2032) & (US$ Million) Figure 60. Saudi Arabia Renal Drugs Market Size (2021-2032) & (US$ Million) Figure 61. Turkey Renal Drugs Market Size (2021-2032) & (US$ Million) Figure 62. Argentina Renal Drugs Market Size (2021-2032) & (US$ Million) Figure 63. UAE Renal Drugs Market Size (2021-2032) & (US$ Million) Figure 64. Egypt Renal Drugs Market Size (2021-2032) & (US$ Million) Figure 65. Chile Renal Drugs Market Size (2021-2032) & (US$ Million) Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Oral
  • Injections
Applications
  • Hospital Pharmacy
  • Drug Stores
  • Online Pharmacy
  • Retail Pharmacies
  • Others
Companies covered
  • Mylan
  • Roche Holding
  • Fresenius
  • Endo International
  • Dava Pharmaceuticals
  • Cardinal Health
  • Bausch Health Companies
  • Apotex

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Renal Drugs Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Oral
  5. 1.2.3 Injections
  6. 1.3 Market Analysis by Application
  7. 1.3.1 Global Renal Drugs Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  8. 1.3.2 Hospital Pharmacy
  9. 1.3.3 Drug Stores
  10. 1.3.4 Online Pharmacy
  11. 1.3.5 Retail Pharmacies
  12. 1.3.6 Others
  13. 1.4 Global Market Growth Prospects
  14. 1.5 Global Renal Drugs Growth Trends by Region
  15. 1.5.1 Global Renal Drugs Market Size by Region: 2021 VS 2025 VS 2032
  16. 1.5.2 Renal Drugs Market Size by Region (2021-2026)
  17. 1.5.3 Renal Drugs Market Size by Region (2027-2032)
  18. 1.6 Assumptions and Limitations
  19. 1.7 Study Goals and Objectives
  20. 1.8 Years Considered
2 Global Renal Drugs Market Dynamics
  1. 2.1 Renal Drugs Industry Trends
  2. 2.2 Renal Drugs Industry Drivers
  3. 2.3 Renal Drugs Industry Opportunities and Challenges
  4. 2.4 Renal Drugs Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Renal Drugs Revenue by Company (2021-2026)
  2. 3.2 Global Renal Drugs Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Renal Drugs Key Company Head office and Area Served
  4. 3.4 Global Renal Drugs Company, Product Type & Application
  5. 3.5 Global Renal Drugs Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Renal Drugs Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Renal Drugs Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Renal Drugs Tier 1, Tier 2, and Tier 3
4 Renal Drugs Market by Type
  1. 4.1 Global Renal Drugs Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Renal Drugs Market Size by Type (2021-2032)
  3. 4.3 Global Renal Drugs Market Size Share by Type (2021-2032)
5 Renal Drugs Market by Application
  1. 5.1 Global Renal Drugs Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Renal Drugs Market Size by Application (2021-2032)
  3. 5.3 Global Renal Drugs Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Mylan
  2. 6.1.1 Mylan Company Information
  3. 6.1.2 Mylan Business Overview
  4. 6.1.3 Mylan Renal Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Mylan Renal Drugs Product Portfolio
  6. 6.1.5 Mylan Recent Developments
  7. 6.2 Roche Holding
  8. 6.2.1 Roche Holding Company Information
  9. 6.2.2 Roche Holding Business Overview
  10. 6.2.3 Roche Holding Renal Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Roche Holding Renal Drugs Product Portfolio
  12. 6.2.5 Roche Holding Recent Developments
  13. 6.3 Fresenius
  14. 6.3.1 Fresenius Company Information
  15. 6.3.2 Fresenius Business Overview
  16. 6.3.3 Fresenius Renal Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Fresenius Renal Drugs Product Portfolio
  18. 6.3.5 Fresenius Recent Developments
  19. 6.4 Endo International
  20. 6.4.1 Endo International Company Information
  21. 6.4.2 Endo International Business Overview
  22. 6.4.3 Endo International Renal Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Endo International Renal Drugs Product Portfolio
  24. 6.4.5 Endo International Recent Developments
  25. 6.5 Dava Pharmaceuticals
  26. 6.5.1 Dava Pharmaceuticals Company Information
  27. 6.5.2 Dava Pharmaceuticals Business Overview
  28. 6.5.3 Dava Pharmaceuticals Renal Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Dava Pharmaceuticals Renal Drugs Product Portfolio
  30. 6.5.5 Dava Pharmaceuticals Recent Developments
  31. 6.6 Cardinal Health
  32. 6.6.1 Cardinal Health Company Information
  33. 6.6.2 Cardinal Health Business Overview
  34. 6.6.3 Cardinal Health Renal Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Cardinal Health Renal Drugs Product Portfolio
  36. 6.6.5 Cardinal Health Recent Developments
  37. 6.7 Bausch Health Companies
  38. 6.7.1 Bausch Health Companies Company Information
  39. 6.7.2 Bausch Health Companies Business Overview
  40. 6.7.3 Bausch Health Companies Renal Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Bausch Health Companies Renal Drugs Product Portfolio
  42. 6.7.5 Bausch Health Companies Recent Developments
  43. 6.8 Apotex
  44. 6.8.1 Apotex Company Information
  45. 6.8.2 Apotex Business Overview
  46. 6.8.3 Apotex Renal Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Apotex Renal Drugs Product Portfolio
  48. 6.8.5 Apotex Recent Developments
7 North America
  1. 7.1 North America Renal Drugs Market Size (2021-2032)
  2. 7.2 North America Renal Drugs Market Size by Type
  3. 7.2.1 North America Renal Drugs Market Size by Type (2021-2026)
  4. 7.2.2 North America Renal Drugs Market Size by Type (2027-2032)
  5. 7.2.3 North America Renal Drugs Market Share by Type (2021-2032)
  6. 7.3 North America Renal Drugs Market Size by Application
  7. 7.3.1 North America Renal Drugs Market Size by Application (2021-2026)
  8. 7.3.2 North America Renal Drugs Market Size by Application (2027-2032)
  9. 7.3.3 North America Renal Drugs Market Share by Application (2021-2032)
  10. 7.4 North America Renal Drugs Market Size by Country
  11. 7.4.1 North America Renal Drugs Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Renal Drugs Market Size by Country (2021-2026)
  13. 7.4.3 North America Renal Drugs Market Size by Country (2027-2032)
  14. 7.4.4 North America Renal Drugs Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Renal Drugs Market Size (2021-2032)
  2. 8.2 Europe Renal Drugs Market Size by Type
  3. 8.2.1 Europe Renal Drugs Market Size by Type (2021-2026)
  4. 8.2.2 Europe Renal Drugs Market Size by Type (2027-2032)
  5. 8.2.3 Europe Renal Drugs Market Share by Type (2021-2032)
  6. 8.3 Europe Renal Drugs Market Size by Application
  7. 8.3.1 Europe Renal Drugs Market Size by Application (2021-2026)
  8. 8.3.2 Europe Renal Drugs Market Size by Application (2027-2032)
  9. 8.3.3 Europe Renal Drugs Market Share by Application (2021-2032)
  10. 8.4 Europe Renal Drugs Market Size by Country
  11. 8.4.1 Europe Renal Drugs Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Renal Drugs Market Size by Country (2021-2026)
  13. 8.4.3 Europe Renal Drugs Market Size by Country (2027-2032)
  14. 8.4.4 Europe Renal Drugs Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Renal Drugs Market Size (2021-2032)
  2. 9.2 China Renal Drugs Market Size by Type
  3. 9.2.1 China Renal Drugs Market Size by Type (2021-2026)
  4. 9.2.2 China Renal Drugs Market Size by Type (2027-2032)
  5. 9.2.3 China Renal Drugs Market Share by Type (2021-2032)
  6. 9.3 China Renal Drugs Market Size by Application
  7. 9.3.1 China Renal Drugs Market Size by Application (2021-2026)
  8. 9.3.2 China Renal Drugs Market Size by Application (2027-2032)
  9. 9.3.3 China Renal Drugs Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Renal Drugs Market Size (2021-2032)
  2. 10.2 Asia Renal Drugs Market Size by Type
  3. 10.2.1 Asia Renal Drugs Market Size by Type (2021-2026)
  4. 10.2.2 Asia Renal Drugs Market Size by Type (2027-2032)
  5. 10.2.3 Asia Renal Drugs Market Share by Type (2021-2032)
  6. 10.3 Asia Renal Drugs Market Size by Application
  7. 10.3.1 Asia Renal Drugs Market Size by Application (2021-2026)
  8. 10.3.2 Asia Renal Drugs Market Size by Application (2027-2032)
  9. 10.3.3 Asia Renal Drugs Market Share by Application (2021-2032)
  10. 10.4 Asia Renal Drugs Market Size by Country
  11. 10.4.1 Asia Renal Drugs Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Renal Drugs Market Size by Country (2021-2026)
  13. 10.4.3 Asia Renal Drugs Market Size by Country (2027-2032)
  14. 10.4.4 Asia Renal Drugs Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Renal Drugs Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Renal Drugs Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Renal Drugs Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Renal Drugs Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Renal Drugs Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Renal Drugs Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Renal Drugs Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Renal Drugs Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Renal Drugs Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Renal Drugs Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Renal Drugs Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Renal Drugs Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Renal Drugs Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Renal Drugs Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst